News
- Author:
- Ted Bosworth
Publish date: February 14, 2023
Two biomarkers, elastase-DNA and HMGB1-DNA, correlate with poor outcomes in patients with lupus nephritis.
News
- Author:
- Ted Bosworth
Publish date: February 14, 2023
A real-world analysis of the impact of biosimilar switches over 3 years of follow-up addresses the limitations of formal trials in assessing discon...
News
- Author:
- Ted Bosworth
Publish date: January 30, 2023
A large population analysis implicates PCSK9 as a target in prevention of psoriasis.
News
- Author:
- Ted Bosworth
Publish date: January 13, 2023
When dual was replaced by single antiplatelet therapy 1 month after PCI in Japanese patients, bleeding risk declined.
News
- Author:
- Ted Bosworth
Publish date: November 28, 2022
The risk is particularly acute for powdered formulations, presumably because powder more easily disseminates to contaminate central venous catheter...
News
- Author:
- Ted Bosworth
Publish date: November 15, 2022
The SPYRAL HTN–ON MED trial missed its primary endpoint, likely caused in part by imbalances in medication use.
News
- Author:
- Ted Bosworth
Publish date: November 10, 2022
Atrial fibrillation treated with ablation rather than drug therapy was less likely to progress to persistent symptoms in the PROGRESSIVE-AF trial.<...
News
- Author:
- Ted Bosworth
Publish date: November 9, 2022
Surgery beats endovascular treatment for limb threatening ischemia when saphenous grafts are an option, according to the BEST-CLI trial.
News
- Author:
- Ted Bosworth
Publish date: November 7, 2022
A streamlined protocol for evaluating suspected stable chest pain substantially improved outcomes at 1 year in the PRECISE trial.
News
- Author:
- Ted Bosworth
Publish date: November 6, 2022
With more than 15 years of follow-up, the radial artery beats other options for the second key coronary target in coronary artery bypass surgery.
News
- Author:
- Ted Bosworth
Publish date: November 5, 2022
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on cardiovascula...
News
- Author:
- Ted Bosworth
Publish date: November 4, 2022
“When stratified by severity of COPD at the time of admission, the difference in the readmission rate was even greater.”
News
- Author:
- Ted Bosworth
Publish date: November 4, 2022
For young men complaining of hypogonadal symptoms, new reference testosterone ranges may have clinical use, but experts have their doubts.
News
- Author:
- Ted Bosworth
Publish date: October 25, 2022
“I think it is really important that children with asthma finish their childhood with the best bone health and the lowest risk of other steroid-ass...
News
- Author:
- Ted Bosworth
Publish date: October 20, 2022
“If the advice is interpreted as aiding and abetting an elective abortion, it is a felony offense in some states.”
